The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
Open Access
- 2 July 2022
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 22 (4) , 247-249
Abstract
Genetic variation in genes encoding cytochrome P450 enzymes influences the metabolism of drugs and endogenous compounds. The locus containing the cytochrome genes CYP2C8 and CYP2C9 on chromosome 10 exhibits linkage disequilibrium between the CYP2C8*3 and CYP2C9*2 alleles, forming a haplotype of ~300 kilobases. This haplotype is associated with altered metabolism of several drugs, most notably reduced metabolism of warfarin and phenytoin, leading to toxicity at otherwise therapeutic doses. Here we show that this haplotype is inherited from Neandertals.Keywords
Funding Information
- Vetenskapsrådet
- NOMIS Stiftung
This publication has 20 references indexed in Scilit:
- The phenotypic legacy of admixture between modern humans and NeandertalsScience, 2016
- A global reference for human genetic variationNature, 2015
- The complete genome sequence of a Neanderthal from the Altai MountainsNature, 2013
- PharmGKB summaryPharmacogenetics and Genomics, 2013
- A High-Coverage Genome Sequence from an Archaic Denisovan IndividualScience, 2012
- Genetic history of an archaic hominin group from Denisova Cave in SiberiaNature, 2010
- Fine-scale recombination rate differences between sexes, populations and individualsNature, 2010
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populationsEuropean Journal of Clinical Pharmacology, 2010
- A Draft Sequence of the Neandertal GenomeScience, 2010
- Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees.Molecular Biology and Evolution, 1993